somatropin: profile and news
Pfizer's Genotropin (Somatropin [rDNA origin] for Injection) ... May 4, 2006
...announced today that the US Food and Drug Administration (FDA) has approved a supplemental new drug application for Genotropin® (somatropin [rDNA origin] for ... - DG News
International Approvals: Omnitrope, Prograf, Cetrotide May 1, 2006
May 1, 2006 — The European Commission has approved a generic formulation of somatropin for use as long-term replacement therapy in children and adults, and a ... - Medscape (subscription)
Phase III Trial Of Oral Cladribine, A Novel Investigational ... May 5, 2006
...for injection), Luveris(R) (lutropin alfa), Ovidrel PreFilled Syringe(R)/Ovitrelle(R) (choriogonadotropin alfa injection), Serostim(R) [somatropin (rDNA origin ... - Medical News Today (press release),
Biogeneric race in Europe heats up May 12, 2006
Both drugs are based on somatropin, a growth hormone produced by recombinant DNA technology, and are set to compete with other products on the European market ... - In-PharmaTechnologist.com,
DSHS May Owe Millions: $1 Billion in 'Questioned Costs' Cited Apr 28, 2006
Social Security numbers.". --The state is paying widely-varying prices for the human growth steroid Somatropin. Auditors say that ... - International News Service,
Court Says Agency must decide on Generic HGH Apr 26, 2006
...on Medicinal Products for Human Use has already given a positive recommendation for another human growth hormone, Valtropin (somatropin) by Biopartners GmbH ... - PharmExec.com,
Launch Of Europe's First Biogeneric Drug Imminent Apr 18, 2006
Sandoz GmbH plans to launch Europe's first biogeneric drug, Omnitrope (somatropin), within a matter of days, following the European Commission's decision ... - BioWorld Online (subscription),
Lilly Reports Q1 EPS of $.77, or 13% Growth Apr 20, 2006
Humalog(R) Mix 50/50(TM) (50% insulin lispro protamine suspension, 50% insulin lispro injection (rDNA origin, Lilly) Humatrope(R) (somatropin of recombinant ... - MSN Money
Injectable Generic Drugs: Prospects and Opportunities to 2010 Apr 28, 2006
...to take an interest in some of the older high value biopharmaceuticals, including erythropoietin, filgrastim, recombinant insulin, somatropin and interferon. ... - Genetic Engineering News,
